Crombez Eric 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Apr 19, 2024
Insider Transaction Report
Form 4
Crombez Eric
EVP and Chief Medical Officer
Transactions
- Sale
Common Stock
2024-04-18$44.10/sh−142$6,262→ 48,785 total
Footnotes (2)
- [F1]Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.